Survivorship and Quality of Life in Head and Neck Cancer
Ce dossier présente un ensemble d'articles sur la prise en charge de certains cancers de la tête et du cou (larynx, pharynx, cavité buccale, ...) et aborde l'épidémiologie des carcinomes épidermoïdes liés au papillomavirus humain ainsi que les anomalies et interactions moléculaires pouvant favoriser le développement de tumeurs rhinopharyngées
Head and neck cancer is becoming more common, and survival rates are improving. Human papillomavirus–associated oropharyngeal cancer, in particular, is increasing in incidence and is associated with an excellent prognosis. However, toxicity from disease and treatment leads to long-term impairment, disability, and handicap. Currently, more than 60% of survivors have unmet needs. As the numbers of survivors increase, current models of care will be increasingly inadequate to meet their needs. Exploration of new strategies and models of care to better address quality-of-life issues and meet the needs of survivors of head and neck cancer is urgently required.
Journal of Clinical Oncology , résumé, 2015